Table Graph
      published meta-analysis   sensitivity analysis   studies

placebo in infections other than COVID-19 - Summary of results

OutcomeTE95% CInkI2ROBPub. bias clinical improvementdetailed resultsBorges, 2013 (REV) 0.03 [0.00; 0.56] Peymani, 2016 (REV) 0.01 [0.00; 0.82] Tricou, 2010 (REV) 1.25 [0.96; 1.63] 0.12[0.00; 3.14]Borges, 2013 (REV), Peymani, 2016 (REV), Tricou, 2010 (REV)382%693moderatenot evaluable Influenza-like infectiondetailed resultsPaton, 2011 (REV) 0.65 [0.26; 1.60] 0.65[0.26; 1.60]Paton, 2011 (REV)10%1,462NAnot evaluable0.02.01.0relative treatment effectwww.metaEvidence.org2024-08-20 16:00 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 92 - treatments: 650 - roots T: 650

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons